
The end came very quickly for the Pfizer/Allergan $160 billion deal once the US Treasury Department announced a new set …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

